Every 10-Q that OMNIQ CORP (OMQS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow OMQS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OMQS filings page.
OMNIQ Corp. (OMQS) reported weaker results for the six months ended June 30, 2026, with revenue of $15.1 million, down about 5% from 2025, and a loss from operations of $3.5 million versus a $0.7 million loss a year earlier. Net loss from continuing operations was $2.4 million compared with income of $1.7 million in 2025, as operating expenses rose nearly 50% to $7.3 million, mainly from higher selling, general and administrative costs.
The balance sheet remains highly stressed: OMNIQ reported a working capital deficit of $15.2 million, a stockholders’ deficit of $14.9 million, and an accumulated deficit of $126.4 million. Total liabilities of $40.0 million exceed total assets of $25.1 million, and management highlights substantial doubt about the company’s ability to continue as a going concern. Cash was $1.1 million, with $0.9 million of operating cash inflow year‑to‑date, but the company is out of compliance with certain Bank Leumi and Bank Hapoalim covenants, leading to reclassification of that debt as current.
The company relies heavily on related parties, including $7.3 million in non‑interest‑bearing advances and a $9.2 million related‑party promissory note. Management also discloses a material weakness in internal control over financial reporting related to segregation of duties, and concludes both disclosure controls and internal controls were not effective as of June 30, 2026. A prior Israeli lease dispute originally seeking about $5.6 million was settled in July 2026 for roughly $525,000 payable over four years.
OMNIQ Corp. reported a wider operating loss and continued financial strain for the quarter ended March 31, 2026. Revenue from continuing operations was $7.7 million, down slightly from $8.0 million a year earlier, while loss from operations increased to $1.3 million. Net loss was $1.7 million versus $2.1 million in 2025, and basic and diluted loss per share from continuing operations was $0.11.
The balance sheet remains highly leveraged, with a working capital deficit of $14.6 million, stockholders’ deficit of $14.1 million, and accumulated deficit of $125.7 million as of March 31, 2026. Management discloses substantial doubt about the company’s ability to continue as a going concern, citing multiple years of operating losses, covenant breaches on Israeli bank debt that led to reclassification of those borrowings as current, and reliance on related-party advances, including a $9.4 million promissory note tied to the 2025 sale of its Quest division.
OMNIQ Corp. (OTC: OMQS) filed its Q3 2025 10‑Q, reflecting a slimmer business after a mid‑year divestiture and ongoing liquidity pressure. For the nine months ended September 30, 2025, revenue from continuing operations was $24.2 million (down ~10%), while cost control lifted gross profit to $7.1 million and reduced the operating loss to $1.3 million from $3.1 million a year ago. Continuing operations generated income of $0.9 million, but a loss in discontinued operations led to a net loss of $0.8 million.
Cash was $679 thousand with a working capital deficit of $11.8 million as of September 30, 2025. Management disclosed substantial doubt about the company’s ability to continue as a going concern and noted noncompliance with certain bank covenants; related debt was reclassified as current, and lenders had not demanded early repayment. Operating cash flow improved to $5.4 million.
OMNIQ completed the sale of a division (effective June 30, 2025) for aggregate consideration of approximately $45 million (including assumption of up to $55 million in specified liabilities and a $10 million 5% promissory note). The transaction produced a $34.7 million gain recorded to additional paid‑in capital due to its related‑party nature, shrinking stockholders’ deficit to $13.1 million. Shares outstanding were 11,602,930 as of November 4, 2025.